334 Aidisheng Rd.,Zhangjiang High-Tech Park,
Shanghai 201203 China
Tel:+86(0)21 6089 3288
Fax:+86(0)21 6089 3290
Tel：+1 6304323100 (US)
?Viva Biotech (Shanghai) Ltd. 沪ICP备12042930号 Powerd by 300.cn
Viva Biotech Shanghai was recognized as a Technically Advanced Service Enterprise.
Developed G-protein-coupled receptors (“GPCR”) membrane protein targets technology platform.
? Viva Biotech Shanghai was recognized as a High-tech Enterprise.
? Filed three patents on fusion expression of membrane proteins and ASMS screening methodology with purified membrane proteins.
A record of 1000 new drug target proteins were studied by us with over 7000 independent crystal structures delivered.
Obtained pathogenic microorganism laboratory filing certificate.
Incorporated in the PRC and commenced operation in an office
Commenced the construction of a research center in Jiaxing, Zhejiang Province.
? Avenue Capital Group became our strategic investor.
? Established the Department of Chemistry and Department of In-vitro Assay and started providing structure-based drug discovery services.
Developed a 6,000-membered library targeting GPCR and started to offer screening services.
Developed a proprietary fragment compound library and the ASMS screening technology and integrated with SBDD services.
One of our clients announced a Phase I study in patients of a compound developed from scratch with considerable effort from our scientists utilizing SBDD.